• Daniel Pinggera, Johannes Kerschbaumer, Lukas Grassner, Matthias Demetz, Sebastian Hartmann, and Claudius Thomé.
• Department of Neurosurgery, Medical University Innsbruck, Innsbruck, Austria. Electronic address: daniel.pinggera@tirol-kliniken.at.
• World Neurosurg. 2021 May 1; 149: e274e280e274-e280.

BackgroundThe world currently faces the novel COVID-19 pandemic, with cutbacks in patient care. Little is known about the effects of a pandemic on the presentation and admission to an outpatient clinic. Our aim was to gain a better understanding of the effects of reduced neurosurgical care access from the patient perspective, especially in terms of anxiety and urgency of treatment, and to improve outpatient management in case of a potential second wave and potential restrictions on health care.MethodsWe performed a questionnaire study over a period of 4 weeks following the COVID-19 lockdown at our academic neurosurgical department. A 15-item questionnaire was distributed to the patients with 3 additional questions to be answered by the treating neurosurgeon.ResultsA total of 437 questionnaires were analyzed. Overall anxiety to visit a general practitioner or the outpatient facility within the hospital was very low among patients. A quarter of all appointments had to be postponed due to COVID-19, in 0.6% postponement was perceived as incorrect by the treating neurosurgeon. We noted that 43% did not get an appointment due to the restrictions, 20% did not want to bother the medical system, and only 4% were afraid to get infected in the hospital.ConclusionsDespite COVID-19, patients in need of neurosurgical service were hardly afraid to visit doctors and/or hospitals. Nonetheless, because legal requirements, access has been restricted, causing potential collateral damage in a small subset of neurosurgical patients.Copyright © 2021 Elsevier Inc. All rights reserved.

27 keywords...

hide…